Eukles Asset Management’s Pfizer PFE Stock Holding History

Eukles Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Hold	45	–	–	﹤0.01%	204
2026 Q1	$1.26K	Hold	45	–	–	﹤0.01%	208
2025 Q4	$1.12K	Hold	45	–	–	﹤0.01%	210
2025 Q3	$1.15K	Hold	45	–	–	﹤0.01%	218
2025 Q2	$1.09K	Hold	45	–	–	﹤0.01%	218
2025 Q1	$1.14K	Hold	45	–	–	﹤0.01%	201
2024 Q4	$1.19K	Hold	45	–	–	﹤0.01%	205
2024 Q3	$1.3K	Hold	45	–	–	﹤0.01%	215
2024 Q2	$1.26K	Hold	45	–	–	﹤0.01%	214
2024 Q1	$1.25K	Hold	45	–	–	﹤0.01%	214
2023 Q4	$1.3K	Hold	45	–	–	﹤0.01%	222
2023 Q3	$1.49K	Hold	45	–	–	﹤0.01%	218
2023 Q2	$1.65K	Hold	45	–	–	﹤0.01%	212
2023 Q1	$1.84K	Hold	45	–	–	﹤0.01%	196
2022 Q4	$2K	Hold	45	–	–	﹤0.01%	194
2022 Q3	$2K	Buy	+45	New	+$2.19K	﹤0.01%	192

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eukles Asset Management's PFE Position: Q2 2026 in Review

Eukles Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 45 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #204.

Eukles Asset Management first reported a position in PFE in Q3 2022 and has held it in 16 quarters since. The position peaked at $2K in Q4 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Eukles Asset Management held 45 shares of Pfizer worth $1.08K as of Q2 2026.
Eukles Asset Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of Eukles Asset Management's portfolio in Q2 2026, its #204 holding.
Eukles Asset Management first reported a position in Pfizer in Q3 2022 and has held it in 16 quarters since.
Eukles Asset Management's Pfizer position peaked at $2K in Q4 2022.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Eukles Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.